Browsing: History

On August 5, Eli Lilly released its 2026 first-half performance report. One number took the entire pharmaceutical industry’s breath away: Tirzepatide — the glycemia-lowering version Mounjaro and the weight-loss version Zepbound — posted combined revenue of 27.693 billion US dollars in the first half of the year, representing an 88% year-on-year increase

Have you ever watched an NCAA meet and noticed how often routines score a 9.85? Do you ever get a sense of deja vu watching the same gymnast, week after week, getting 9.85s? It almost feels like a default. But is it? And has it always been? We dove into the data to find out

A LARGE Danish study has revealed that hormonal contraception use is associated with subsequent initiation of GLP-1 receptor agonists, particularly among women with a history of using multiple contraceptive types, raising new questions about weight management in women.